December 15, 2017 / 9:18 AM / a year ago

BRIEF-Hybio Pharmaceutical receives patent licenses

Dec 15(Reuters) - Hybio Pharmaceutical Co Ltd

* Says it received patent licenses (No. ZL 2013 1 0078240.9, ZL 2014 1 0283043.5, ZL 2013 1 0430508.0), regarding synthetic method of liraglutide, bromocriptine composition sustained-release preparation and preparation method and rivaroxaban preparation method

Source text in Chinese: goo.gl/n9E4Lb

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below